0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Biopharmaceutical CMO Services Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-31E5654
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Biopharmaceutical CMO Services Market Insights Forecast to 2028
BUY CHAPTERS

Global Biopharmaceutical CMO Services Market Research Report 2025

Code: QYRE-Auto-31E5654
Report
July 2025
Pages:97
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Biopharmaceutical CMO Services Market

The global market for Biopharmaceutical CMO Services was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Contract Pharmaceutical Manufacturing refers to accept commissioned from pharmaceutical companies, provide the service about API production, agent production, packaging and son on which required for pharmaceutical manufacturing.
In terms of regions, North America is expected to remain the largest market during the forecast period.
This report aims to provide a comprehensive presentation of the global market for Biopharmaceutical CMO Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biopharmaceutical CMO Services.
The Biopharmaceutical CMO Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biopharmaceutical CMO Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biopharmaceutical CMO Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Biopharmaceutical CMO Services Market Report

Report Metric Details
Report Name Biopharmaceutical CMO Services Market
Segment by Type
  • Biologics Manufacturing
  • Biosimilars Manufacturing
  • Others
Segment by Application
  • Clinical Manufacturing
  • Commercial Manufacturing
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Catalent, Thermo Fisher Scientific, Lonza, Boehringer Ingelheim, Fareva, Recipharm, Aenova, AbbVie, Baxter, Nipro Corp, Sopharma, Famar, Vetter, Shandong Xinhua, Piramal, Mylan, Dr. Reddy’s, Zhejiang Hisun, Zhejiang Huahai, Jubilant
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Biopharmaceutical CMO Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Biopharmaceutical CMO Services Market report?

Ans: The main players in the Biopharmaceutical CMO Services Market are Catalent, Thermo Fisher Scientific, Lonza, Boehringer Ingelheim, Fareva, Recipharm, Aenova, AbbVie, Baxter, Nipro Corp, Sopharma, Famar, Vetter, Shandong Xinhua, Piramal, Mylan, Dr. Reddy’s, Zhejiang Hisun, Zhejiang Huahai, Jubilant

What are the Application segmentation covered in the Biopharmaceutical CMO Services Market report?

Ans: The Applications covered in the Biopharmaceutical CMO Services Market report are Clinical Manufacturing, Commercial Manufacturing, Others

What are the Type segmentation covered in the Biopharmaceutical CMO Services Market report?

Ans: The Types covered in the Biopharmaceutical CMO Services Market report are Biologics Manufacturing, Biosimilars Manufacturing, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biopharmaceutical CMO Services Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Biologics Manufacturing
1.2.3 Biosimilars Manufacturing
1.2.4 Others
1.3 Market by Application
1.3.1 Global Biopharmaceutical CMO Services Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Clinical Manufacturing
1.3.3 Commercial Manufacturing
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biopharmaceutical CMO Services Market Perspective (2020-2031)
2.2 Global Biopharmaceutical CMO Services Growth Trends by Region
2.2.1 Global Biopharmaceutical CMO Services Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Biopharmaceutical CMO Services Historic Market Size by Region (2020-2025)
2.2.3 Biopharmaceutical CMO Services Forecasted Market Size by Region (2026-2031)
2.3 Biopharmaceutical CMO Services Market Dynamics
2.3.1 Biopharmaceutical CMO Services Industry Trends
2.3.2 Biopharmaceutical CMO Services Market Drivers
2.3.3 Biopharmaceutical CMO Services Market Challenges
2.3.4 Biopharmaceutical CMO Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biopharmaceutical CMO Services Players by Revenue
3.1.1 Global Top Biopharmaceutical CMO Services Players by Revenue (2020-2025)
3.1.2 Global Biopharmaceutical CMO Services Revenue Market Share by Players (2020-2025)
3.2 Global Biopharmaceutical CMO Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Biopharmaceutical CMO Services Revenue
3.4 Global Biopharmaceutical CMO Services Market Concentration Ratio
3.4.1 Global Biopharmaceutical CMO Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biopharmaceutical CMO Services Revenue in 2024
3.5 Global Key Players of Biopharmaceutical CMO Services Head office and Area Served
3.6 Global Key Players of Biopharmaceutical CMO Services, Product and Application
3.7 Global Key Players of Biopharmaceutical CMO Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Biopharmaceutical CMO Services Breakdown Data by Type
4.1 Global Biopharmaceutical CMO Services Historic Market Size by Type (2020-2025)
4.2 Global Biopharmaceutical CMO Services Forecasted Market Size by Type (2026-2031)
5 Biopharmaceutical CMO Services Breakdown Data by Application
5.1 Global Biopharmaceutical CMO Services Historic Market Size by Application (2020-2025)
5.2 Global Biopharmaceutical CMO Services Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Biopharmaceutical CMO Services Market Size (2020-2031)
6.2 North America Biopharmaceutical CMO Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Biopharmaceutical CMO Services Market Size by Country (2020-2025)
6.4 North America Biopharmaceutical CMO Services Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biopharmaceutical CMO Services Market Size (2020-2031)
7.2 Europe Biopharmaceutical CMO Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Biopharmaceutical CMO Services Market Size by Country (2020-2025)
7.4 Europe Biopharmaceutical CMO Services Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biopharmaceutical CMO Services Market Size (2020-2031)
8.2 Asia-Pacific Biopharmaceutical CMO Services Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Biopharmaceutical CMO Services Market Size by Region (2020-2025)
8.4 Asia-Pacific Biopharmaceutical CMO Services Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biopharmaceutical CMO Services Market Size (2020-2031)
9.2 Latin America Biopharmaceutical CMO Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Biopharmaceutical CMO Services Market Size by Country (2020-2025)
9.4 Latin America Biopharmaceutical CMO Services Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biopharmaceutical CMO Services Market Size (2020-2031)
10.2 Middle East & Africa Biopharmaceutical CMO Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Biopharmaceutical CMO Services Market Size by Country (2020-2025)
10.4 Middle East & Africa Biopharmaceutical CMO Services Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Catalent
11.1.1 Catalent Company Details
11.1.2 Catalent Business Overview
11.1.3 Catalent Biopharmaceutical CMO Services Introduction
11.1.4 Catalent Revenue in Biopharmaceutical CMO Services Business (2020-2025)
11.1.5 Catalent Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Biopharmaceutical CMO Services Introduction
11.2.4 Thermo Fisher Scientific Revenue in Biopharmaceutical CMO Services Business (2020-2025)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Lonza
11.3.1 Lonza Company Details
11.3.2 Lonza Business Overview
11.3.3 Lonza Biopharmaceutical CMO Services Introduction
11.3.4 Lonza Revenue in Biopharmaceutical CMO Services Business (2020-2025)
11.3.5 Lonza Recent Development
11.4 Boehringer Ingelheim
11.4.1 Boehringer Ingelheim Company Details
11.4.2 Boehringer Ingelheim Business Overview
11.4.3 Boehringer Ingelheim Biopharmaceutical CMO Services Introduction
11.4.4 Boehringer Ingelheim Revenue in Biopharmaceutical CMO Services Business (2020-2025)
11.4.5 Boehringer Ingelheim Recent Development
11.5 Fareva
11.5.1 Fareva Company Details
11.5.2 Fareva Business Overview
11.5.3 Fareva Biopharmaceutical CMO Services Introduction
11.5.4 Fareva Revenue in Biopharmaceutical CMO Services Business (2020-2025)
11.5.5 Fareva Recent Development
11.6 Recipharm
11.6.1 Recipharm Company Details
11.6.2 Recipharm Business Overview
11.6.3 Recipharm Biopharmaceutical CMO Services Introduction
11.6.4 Recipharm Revenue in Biopharmaceutical CMO Services Business (2020-2025)
11.6.5 Recipharm Recent Development
11.7 Aenova
11.7.1 Aenova Company Details
11.7.2 Aenova Business Overview
11.7.3 Aenova Biopharmaceutical CMO Services Introduction
11.7.4 Aenova Revenue in Biopharmaceutical CMO Services Business (2020-2025)
11.7.5 Aenova Recent Development
11.8 AbbVie
11.8.1 AbbVie Company Details
11.8.2 AbbVie Business Overview
11.8.3 AbbVie Biopharmaceutical CMO Services Introduction
11.8.4 AbbVie Revenue in Biopharmaceutical CMO Services Business (2020-2025)
11.8.5 AbbVie Recent Development
11.9 Baxter
11.9.1 Baxter Company Details
11.9.2 Baxter Business Overview
11.9.3 Baxter Biopharmaceutical CMO Services Introduction
11.9.4 Baxter Revenue in Biopharmaceutical CMO Services Business (2020-2025)
11.9.5 Baxter Recent Development
11.10 Nipro Corp
11.10.1 Nipro Corp Company Details
11.10.2 Nipro Corp Business Overview
11.10.3 Nipro Corp Biopharmaceutical CMO Services Introduction
11.10.4 Nipro Corp Revenue in Biopharmaceutical CMO Services Business (2020-2025)
11.10.5 Nipro Corp Recent Development
11.11 Sopharma
11.11.1 Sopharma Company Details
11.11.2 Sopharma Business Overview
11.11.3 Sopharma Biopharmaceutical CMO Services Introduction
11.11.4 Sopharma Revenue in Biopharmaceutical CMO Services Business (2020-2025)
11.11.5 Sopharma Recent Development
11.12 Famar
11.12.1 Famar Company Details
11.12.2 Famar Business Overview
11.12.3 Famar Biopharmaceutical CMO Services Introduction
11.12.4 Famar Revenue in Biopharmaceutical CMO Services Business (2020-2025)
11.12.5 Famar Recent Development
11.13 Vetter
11.13.1 Vetter Company Details
11.13.2 Vetter Business Overview
11.13.3 Vetter Biopharmaceutical CMO Services Introduction
11.13.4 Vetter Revenue in Biopharmaceutical CMO Services Business (2020-2025)
11.13.5 Vetter Recent Development
11.14 Shandong Xinhua
11.14.1 Shandong Xinhua Company Details
11.14.2 Shandong Xinhua Business Overview
11.14.3 Shandong Xinhua Biopharmaceutical CMO Services Introduction
11.14.4 Shandong Xinhua Revenue in Biopharmaceutical CMO Services Business (2020-2025)
11.14.5 Shandong Xinhua Recent Development
11.15 Piramal
11.15.1 Piramal Company Details
11.15.2 Piramal Business Overview
11.15.3 Piramal Biopharmaceutical CMO Services Introduction
11.15.4 Piramal Revenue in Biopharmaceutical CMO Services Business (2020-2025)
11.15.5 Piramal Recent Development
11.16 Mylan
11.16.1 Mylan Company Details
11.16.2 Mylan Business Overview
11.16.3 Mylan Biopharmaceutical CMO Services Introduction
11.16.4 Mylan Revenue in Biopharmaceutical CMO Services Business (2020-2025)
11.16.5 Mylan Recent Development
11.17 Dr. Reddy’s
11.17.1 Dr. Reddy’s Company Details
11.17.2 Dr. Reddy’s Business Overview
11.17.3 Dr. Reddy’s Biopharmaceutical CMO Services Introduction
11.17.4 Dr. Reddy’s Revenue in Biopharmaceutical CMO Services Business (2020-2025)
11.17.5 Dr. Reddy’s Recent Development
11.18 Zhejiang Hisun
11.18.1 Zhejiang Hisun Company Details
11.18.2 Zhejiang Hisun Business Overview
11.18.3 Zhejiang Hisun Biopharmaceutical CMO Services Introduction
11.18.4 Zhejiang Hisun Revenue in Biopharmaceutical CMO Services Business (2020-2025)
11.18.5 Zhejiang Hisun Recent Development
11.19 Zhejiang Huahai
11.19.1 Zhejiang Huahai Company Details
11.19.2 Zhejiang Huahai Business Overview
11.19.3 Zhejiang Huahai Biopharmaceutical CMO Services Introduction
11.19.4 Zhejiang Huahai Revenue in Biopharmaceutical CMO Services Business (2020-2025)
11.19.5 Zhejiang Huahai Recent Development
11.20 Jubilant
11.20.1 Jubilant Company Details
11.20.2 Jubilant Business Overview
11.20.3 Jubilant Biopharmaceutical CMO Services Introduction
11.20.4 Jubilant Revenue in Biopharmaceutical CMO Services Business (2020-2025)
11.20.5 Jubilant Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Biopharmaceutical CMO Services Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Biologics Manufacturing
 Table 3. Key Players of Biosimilars Manufacturing
 Table 4. Key Players of Others
 Table 5. Global Biopharmaceutical CMO Services Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Biopharmaceutical CMO Services Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Biopharmaceutical CMO Services Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Biopharmaceutical CMO Services Market Share by Region (2020-2025)
 Table 9. Global Biopharmaceutical CMO Services Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Biopharmaceutical CMO Services Market Share by Region (2026-2031)
 Table 11. Biopharmaceutical CMO Services Market Trends
 Table 12. Biopharmaceutical CMO Services Market Drivers
 Table 13. Biopharmaceutical CMO Services Market Challenges
 Table 14. Biopharmaceutical CMO Services Market Restraints
 Table 15. Global Biopharmaceutical CMO Services Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Biopharmaceutical CMO Services Market Share by Players (2020-2025)
 Table 17. Global Top Biopharmaceutical CMO Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical CMO Services as of 2024)
 Table 18. Ranking of Global Top Biopharmaceutical CMO Services Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Biopharmaceutical CMO Services Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Biopharmaceutical CMO Services, Headquarters and Area Served
 Table 21. Global Key Players of Biopharmaceutical CMO Services, Product and Application
 Table 22. Global Key Players of Biopharmaceutical CMO Services, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Biopharmaceutical CMO Services Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Biopharmaceutical CMO Services Revenue Market Share by Type (2020-2025)
 Table 26. Global Biopharmaceutical CMO Services Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Biopharmaceutical CMO Services Revenue Market Share by Type (2026-2031)
 Table 28. Global Biopharmaceutical CMO Services Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Biopharmaceutical CMO Services Revenue Market Share by Application (2020-2025)
 Table 30. Global Biopharmaceutical CMO Services Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Biopharmaceutical CMO Services Revenue Market Share by Application (2026-2031)
 Table 32. North America Biopharmaceutical CMO Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Biopharmaceutical CMO Services Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Biopharmaceutical CMO Services Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Biopharmaceutical CMO Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Biopharmaceutical CMO Services Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Biopharmaceutical CMO Services Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Biopharmaceutical CMO Services Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Biopharmaceutical CMO Services Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Biopharmaceutical CMO Services Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Biopharmaceutical CMO Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Biopharmaceutical CMO Services Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Biopharmaceutical CMO Services Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Biopharmaceutical CMO Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Biopharmaceutical CMO Services Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Biopharmaceutical CMO Services Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Catalent Company Details
 Table 48. Catalent Business Overview
 Table 49. Catalent Biopharmaceutical CMO Services Product
 Table 50. Catalent Revenue in Biopharmaceutical CMO Services Business (2020-2025) & (US$ Million)
 Table 51. Catalent Recent Development
 Table 52. Thermo Fisher Scientific Company Details
 Table 53. Thermo Fisher Scientific Business Overview
 Table 54. Thermo Fisher Scientific Biopharmaceutical CMO Services Product
 Table 55. Thermo Fisher Scientific Revenue in Biopharmaceutical CMO Services Business (2020-2025) & (US$ Million)
 Table 56. Thermo Fisher Scientific Recent Development
 Table 57. Lonza Company Details
 Table 58. Lonza Business Overview
 Table 59. Lonza Biopharmaceutical CMO Services Product
 Table 60. Lonza Revenue in Biopharmaceutical CMO Services Business (2020-2025) & (US$ Million)
 Table 61. Lonza Recent Development
 Table 62. Boehringer Ingelheim Company Details
 Table 63. Boehringer Ingelheim Business Overview
 Table 64. Boehringer Ingelheim Biopharmaceutical CMO Services Product
 Table 65. Boehringer Ingelheim Revenue in Biopharmaceutical CMO Services Business (2020-2025) & (US$ Million)
 Table 66. Boehringer Ingelheim Recent Development
 Table 67. Fareva Company Details
 Table 68. Fareva Business Overview
 Table 69. Fareva Biopharmaceutical CMO Services Product
 Table 70. Fareva Revenue in Biopharmaceutical CMO Services Business (2020-2025) & (US$ Million)
 Table 71. Fareva Recent Development
 Table 72. Recipharm Company Details
 Table 73. Recipharm Business Overview
 Table 74. Recipharm Biopharmaceutical CMO Services Product
 Table 75. Recipharm Revenue in Biopharmaceutical CMO Services Business (2020-2025) & (US$ Million)
 Table 76. Recipharm Recent Development
 Table 77. Aenova Company Details
 Table 78. Aenova Business Overview
 Table 79. Aenova Biopharmaceutical CMO Services Product
 Table 80. Aenova Revenue in Biopharmaceutical CMO Services Business (2020-2025) & (US$ Million)
 Table 81. Aenova Recent Development
 Table 82. AbbVie Company Details
 Table 83. AbbVie Business Overview
 Table 84. AbbVie Biopharmaceutical CMO Services Product
 Table 85. AbbVie Revenue in Biopharmaceutical CMO Services Business (2020-2025) & (US$ Million)
 Table 86. AbbVie Recent Development
 Table 87. Baxter Company Details
 Table 88. Baxter Business Overview
 Table 89. Baxter Biopharmaceutical CMO Services Product
 Table 90. Baxter Revenue in Biopharmaceutical CMO Services Business (2020-2025) & (US$ Million)
 Table 91. Baxter Recent Development
 Table 92. Nipro Corp Company Details
 Table 93. Nipro Corp Business Overview
 Table 94. Nipro Corp Biopharmaceutical CMO Services Product
 Table 95. Nipro Corp Revenue in Biopharmaceutical CMO Services Business (2020-2025) & (US$ Million)
 Table 96. Nipro Corp Recent Development
 Table 97. Sopharma Company Details
 Table 98. Sopharma Business Overview
 Table 99. Sopharma Biopharmaceutical CMO Services Product
 Table 100. Sopharma Revenue in Biopharmaceutical CMO Services Business (2020-2025) & (US$ Million)
 Table 101. Sopharma Recent Development
 Table 102. Famar Company Details
 Table 103. Famar Business Overview
 Table 104. Famar Biopharmaceutical CMO Services Product
 Table 105. Famar Revenue in Biopharmaceutical CMO Services Business (2020-2025) & (US$ Million)
 Table 106. Famar Recent Development
 Table 107. Vetter Company Details
 Table 108. Vetter Business Overview
 Table 109. Vetter Biopharmaceutical CMO Services Product
 Table 110. Vetter Revenue in Biopharmaceutical CMO Services Business (2020-2025) & (US$ Million)
 Table 111. Vetter Recent Development
 Table 112. Shandong Xinhua Company Details
 Table 113. Shandong Xinhua Business Overview
 Table 114. Shandong Xinhua Biopharmaceutical CMO Services Product
 Table 115. Shandong Xinhua Revenue in Biopharmaceutical CMO Services Business (2020-2025) & (US$ Million)
 Table 116. Shandong Xinhua Recent Development
 Table 117. Piramal Company Details
 Table 118. Piramal Business Overview
 Table 119. Piramal Biopharmaceutical CMO Services Product
 Table 120. Piramal Revenue in Biopharmaceutical CMO Services Business (2020-2025) & (US$ Million)
 Table 121. Piramal Recent Development
 Table 122. Mylan Company Details
 Table 123. Mylan Business Overview
 Table 124. Mylan Biopharmaceutical CMO Services Product
 Table 125. Mylan Revenue in Biopharmaceutical CMO Services Business (2020-2025) & (US$ Million)
 Table 126. Mylan Recent Development
 Table 127. Dr. Reddy’s Company Details
 Table 128. Dr. Reddy’s Business Overview
 Table 129. Dr. Reddy’s Biopharmaceutical CMO Services Product
 Table 130. Dr. Reddy’s Revenue in Biopharmaceutical CMO Services Business (2020-2025) & (US$ Million)
 Table 131. Dr. Reddy’s Recent Development
 Table 132. Zhejiang Hisun Company Details
 Table 133. Zhejiang Hisun Business Overview
 Table 134. Zhejiang Hisun Biopharmaceutical CMO Services Product
 Table 135. Zhejiang Hisun Revenue in Biopharmaceutical CMO Services Business (2020-2025) & (US$ Million)
 Table 136. Zhejiang Hisun Recent Development
 Table 137. Zhejiang Huahai Company Details
 Table 138. Zhejiang Huahai Business Overview
 Table 139. Zhejiang Huahai Biopharmaceutical CMO Services Product
 Table 140. Zhejiang Huahai Revenue in Biopharmaceutical CMO Services Business (2020-2025) & (US$ Million)
 Table 141. Zhejiang Huahai Recent Development
 Table 142. Jubilant Company Details
 Table 143. Jubilant Business Overview
 Table 144. Jubilant Biopharmaceutical CMO Services Product
 Table 145. Jubilant Revenue in Biopharmaceutical CMO Services Business (2020-2025) & (US$ Million)
 Table 146. Jubilant Recent Development
 Table 147. Research Programs/Design for This Report
 Table 148. Key Data Information from Secondary Sources
 Table 149. Key Data Information from Primary Sources
 Table 150. Authors List of This Report


List of Figures
 Figure 1. Biopharmaceutical CMO Services Picture
 Figure 2. Global Biopharmaceutical CMO Services Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Biopharmaceutical CMO Services Market Share by Type: 2024 VS 2031
 Figure 4. Biologics Manufacturing Features
 Figure 5. Biosimilars Manufacturing Features
 Figure 6. Others Features
 Figure 7. Global Biopharmaceutical CMO Services Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Biopharmaceutical CMO Services Market Share by Application: 2024 VS 2031
 Figure 9. Clinical Manufacturing Case Studies
 Figure 10. Commercial Manufacturing Case Studies
 Figure 11. Others Case Studies
 Figure 12. Biopharmaceutical CMO Services Report Years Considered
 Figure 13. Global Biopharmaceutical CMO Services Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Biopharmaceutical CMO Services Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Biopharmaceutical CMO Services Market Share by Region: 2024 VS 2031
 Figure 16. Global Biopharmaceutical CMO Services Market Share by Players in 2024
 Figure 17. Global Top Biopharmaceutical CMO Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical CMO Services as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Biopharmaceutical CMO Services Revenue in 2024
 Figure 19. North America Biopharmaceutical CMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Biopharmaceutical CMO Services Market Share by Country (2020-2031)
 Figure 21. United States Biopharmaceutical CMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Biopharmaceutical CMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Biopharmaceutical CMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Biopharmaceutical CMO Services Market Share by Country (2020-2031)
 Figure 25. Germany Biopharmaceutical CMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Biopharmaceutical CMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Biopharmaceutical CMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Biopharmaceutical CMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Biopharmaceutical CMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Biopharmaceutical CMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Biopharmaceutical CMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Biopharmaceutical CMO Services Market Share by Region (2020-2031)
 Figure 33. China Biopharmaceutical CMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Biopharmaceutical CMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Biopharmaceutical CMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Biopharmaceutical CMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Biopharmaceutical CMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Biopharmaceutical CMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Biopharmaceutical CMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Biopharmaceutical CMO Services Market Share by Country (2020-2031)
 Figure 41. Mexico Biopharmaceutical CMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Biopharmaceutical CMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Biopharmaceutical CMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Biopharmaceutical CMO Services Market Share by Country (2020-2031)
 Figure 45. Turkey Biopharmaceutical CMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Biopharmaceutical CMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Biopharmaceutical CMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Catalent Revenue Growth Rate in Biopharmaceutical CMO Services Business (2020-2025)
 Figure 49. Thermo Fisher Scientific Revenue Growth Rate in Biopharmaceutical CMO Services Business (2020-2025)
 Figure 50. Lonza Revenue Growth Rate in Biopharmaceutical CMO Services Business (2020-2025)
 Figure 51. Boehringer Ingelheim Revenue Growth Rate in Biopharmaceutical CMO Services Business (2020-2025)
 Figure 52. Fareva Revenue Growth Rate in Biopharmaceutical CMO Services Business (2020-2025)
 Figure 53. Recipharm Revenue Growth Rate in Biopharmaceutical CMO Services Business (2020-2025)
 Figure 54. Aenova Revenue Growth Rate in Biopharmaceutical CMO Services Business (2020-2025)
 Figure 55. AbbVie Revenue Growth Rate in Biopharmaceutical CMO Services Business (2020-2025)
 Figure 56. Baxter Revenue Growth Rate in Biopharmaceutical CMO Services Business (2020-2025)
 Figure 57. Nipro Corp Revenue Growth Rate in Biopharmaceutical CMO Services Business (2020-2025)
 Figure 58. Sopharma Revenue Growth Rate in Biopharmaceutical CMO Services Business (2020-2025)
 Figure 59. Famar Revenue Growth Rate in Biopharmaceutical CMO Services Business (2020-2025)
 Figure 60. Vetter Revenue Growth Rate in Biopharmaceutical CMO Services Business (2020-2025)
 Figure 61. Shandong Xinhua Revenue Growth Rate in Biopharmaceutical CMO Services Business (2020-2025)
 Figure 62. Piramal Revenue Growth Rate in Biopharmaceutical CMO Services Business (2020-2025)
 Figure 63. Mylan Revenue Growth Rate in Biopharmaceutical CMO Services Business (2020-2025)
 Figure 64. Dr. Reddy’s Revenue Growth Rate in Biopharmaceutical CMO Services Business (2020-2025)
 Figure 65. Zhejiang Hisun Revenue Growth Rate in Biopharmaceutical CMO Services Business (2020-2025)
 Figure 66. Zhejiang Huahai Revenue Growth Rate in Biopharmaceutical CMO Services Business (2020-2025)
 Figure 67. Jubilant Revenue Growth Rate in Biopharmaceutical CMO Services Business (2020-2025)
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
 Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS